1d
Daily Maverick on MSNUS funding cuts imperil African search for HIV vaccineA groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in ...
Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...
Protein crystallization at the SER-CAT beamline at Argonne’s Advanced Photon Source proved key to the discovery of a new HIV vaccine candidate.
3d
AllAfrica on MSNAfrica: U.S. Funding Cuts Imperil Search for HIV VaccineBlog - A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt ...
The Florida surgeon general in January called for a halt in the use of covid mRNA vaccines. And in Texas, Attorney General ...
A German court on Wednesday ruled that Pfizer and its partner BioNTech violated a COVID-19 vaccine patent held by Moderna .
The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in ...
“The companies told the PTAB in the petitions that Moderna’s patents include ‘unimaginably broad claims directed to a basic idea.’” Patent Trial and Appeal Board (PTAB) docket entries ...
The second vaccine, developed by Moderna in partnership with the National Institute of Allergy and Infectious Diseases, got the greenlight from the FDA days later. These steps are now overlapping ...
22d
Barchart on MSNWall Street Thinks This Beaten-Down Growth Stock Can Soar 85% in 2025. Should You Buy It Now?Last year, the stock declined 62.6%, significantly underperforming the S&P 500 Index’s ($SPX) gain of 25%. Moderna reported its fourth quarter and full fiscal 2024 results last week. So far this year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results